Objective: Vulvar intraepithelial neoplasia (VIN) and vulvar Paget disease are managed with either vulvectomy, destructive treatments (laser, antimitotic drugs) or immunostimulants. All these options are associated with functional complications. The purpose of this study was to evaluate the surgical technique consisting of skinning vulvectomy with split-thickness skin graft, and its effect on overall quality of life and sexual function. 
Introduction
Vulvar intraepithelial neoplasia (VIN) causes pain and itching and can have major psychological and sexual repercussions. Incidence is low (5 new cases for 100,000 women divides VIN into usual-type VIN and differentiated-type VIN 3 . Usual-type VIN affects women between the age of 30 and 50 and is strongly associated with high-risk HPV 4 . Differentiated-type VIN affects older women often presenting lichen sclerosus. There is also vulvar Paget disease, which is an adenocarcinoma with intraepithelial development in the malpighian layer 5 . VIN and Paget disease are intraepithelial lesions and can be associated with invasive lesions [6] [7] [8] . Management of these lesions involves monitoring symptoms, preventing invasion and preserving normal vulvar anatomy and function. Radical local excision is the standard treatment as it enables histological analysis with detection of potential invasion but it often compromises vulvar anatomy with major repercussions on quality of life and sexual function 9 10 . Destructive treatments (such as laser vaporization) 11 or immunostimulants (such as imiquimod) 12 13 have disadvantages, including local side effects and a lack of histological analysis of the full lesions.
Split-thickness skin graft is a common reparative surgical technique 14 . For patients with VIN or vulvar Paget disease, the skinning vulvectomy with a split-thickness skin graft appears to offer an interesting option for preventing the psychosexual disorders related to mutilating vulvar surgery. This surgical approach was described for the first time in 1968 15 then resumed in 1986 16 . The technique has been little used and never been assessed at the functional level.
The purpose of this study was to evaluate the surgical technique consisting of split-thickness skin graft after skinning vulvectomy, along with its impact on the overall quality of life and The outcome measures were the rate of cancer found at final pathological analysis of vulvectomy, quality of life and sexual function of patients.
The medical records and outpatient records were reviewed.
Surgical procedure
After a preoperative diagnosis based on biopsy findings, the patients were operated on under general or regional anesthesia in the lithotomy position. The procedure was performed by a two-surgeon team including a gynecology surgeon and a plastic surgeon. It involved excision of the epidermis and the dermis extending beyond the lesions (≥ 5 mm) and preserving the subcutaneous tissue. The split-thickness skin graft was taken from the inner aspect of the thigh with a Braun air dermatome or a Dufourmentel surgical razor (0.012 in. thick). The graft was applied to the wound following vulvectomy. The surrounding edges were sutured with 4/0 Vicryl absorbable sutures, achieving a tension-free closure. A bolster dressing was applied for 3 to 4 days to optimize adherence ( Figure 1 ). We assessed postoperative pain according to both a visual analog scale (VAS) rated from 0 to 10 and postoperative analgesic requirements.
Pathological analysis
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Preoperative biopsy specimens were fixed in 10% formaldehyde and embedded in paraffin.
Each biopsy was examined using multiple semi-serial sections. According to the established criteria (ISSVD) 3 , we included cases of usual-type and differentiated-type VIN and Paget disease. The surgical resection specimens were oriented by the surgeon and sent fresh directly to the Pathology Department. They were pinned to a rigid board and fixed in 10% formaldehyde for 24 hours. All surgical margins were marked with India ink. The samples taken concerned the excision margins examined in full, the entire operative specimen examined in stages and the entire macroscopic lesion. The slides were reviewed by two pathologists (S.H. and Florence Burtin, MD).
Functional assessment
In December 2009, the patients were contacted for the study. 
Statistical analysis
We used SAS (Statistical Analysis System) version 9.2 software. Continuous variables were compared with Student's t-test and categorical variables were compared with the Chi 2 test or Fisher's exact test, as appropriate. We used Student's t-test which compares the mean value observed with a known mean of the reference population for the MOS SF-36 22 . P values <0.05 were considered statistically significant. Progression-free survival was analyzed using the Kaplan-Meier method. inserm-00871204, version 1 -9 Oct 2013
Results
Epidemiological and clinical characteristics of the study population
During the study period, 13 women referred for VIN or Paget disease underwent skinning vulvectomy with split-thickness skin graft. The median age of patients was 54 (range: years. Body mass index median was 23 (range: 20-36) kg/m². Among the patients, 4 had a history of cervical disease, and 5 had a history of vulvovaginal disease, two of whom had undergone vulvar surgery. Six patients were smokers. Indications for performing skinning vulvectomy were usual-type VIN in 9 cases, differentiated-type VIN in one case and vulvar Paget disease in 3 cases determined from the preoperative biopsy (Table 1) 
Follow-up and determinants of recurrence
The mean follow-up period was 77 (±35) months. Mean disease-free survival for the population was 58 (±44) months (Figure 2 ). The disease-free survival rate was 73% at 2 years and 64% at 5 years. Four patients (31%) relapsed during follow-up. The mean time to recurrence was 19 (±13) months. All cases of recurrence were marked by the re-emergence of vulvar symptoms such as pruritus, burning sensation or pain. One patient experienced a relapse of Paget disease 16 months after surgery. One patient experienced a relapse of usualtype VIN 10 months after surgery. Lastly, 2 patients relapsed with invasive disease 16 and 32 months from surgery, respectively.
Evaluation of quality of life and sexual function after skinning vulvectomy with split-thickness skin graft for vulvar intraepithelial neoplasia or vulvar Paget disease.
inserm-00871204, version 1 -9 Oct 2013
Among the 13 patients, 11 patients responded to the MOS SF-36 questionnaire. Scores for the SF-36 questionnaire are shown in Table 2 . No significant difference was found when comparing the population that underwent skinning vulvectomy with split-thickness skin graft with the overall female population 19 , regardless of the domain considered (Table 2) .
Among the 13 patients, 10 patients responded to the FSFI questionnaire assessing sexual function. Among the patients, 7 had no sexual activity, and their median age was 70 (38-77) years. The 3 patients who stated having sexual activity had a median age of 34 (33-40) 
Occult cancers
Our study has several limitations such as the retrospective character of the study with no functional assessment before the surgery, the small number of patients or some questionnaires administered many years after surgery. Nevertheless, our study provides interesting information about management of VIN or vulvar Paget disease. In our series, the skinning vulvectomy revealed 4 in 13 cases (31%) of cancer on the final operative specimen. In the literature, occult cancers were found on final histological analysis of the vulvectomy resection specimens in 3 to 22% of cases for VIN 11 16 23 24 and in 16% to 30% of cases for vulvar Paget disease 25 26 . In our study, the higher incidence of occult cancer is probably due to the presence of large multifocal intraepithelial lesions.
Recurrence of intraepithelial vulvar disease
Secondly, recurrence is significantly linked to the size and multifocal nature of the lesions and to positive margins 6 7 11 24 27 . The incidence of involved margins is 54% in our study, comparable with the published radical vulvectomy series which report involved margins of between 47% and 61% of VIN cases 6 7 24 and 54% of vulvar Paget disease cases 26 28 .
Regarding relapse of intraepithelial vulvar lesions, 31% of patients relapsed over a follow-up period of 77 (±35) months in our study, comparable with published surgical series which report a relapse rate of between 26% and 37% for VIN lesions 6 24 27 and 47% for vulvar Paget . The sexual function assessments suffers the same difficulties: DSM IV criteria were used by Green and al 9 and FSFI was used by us or others 10 . Furthermore, scores were not always well reported: Likes et col reported correlations with FSFI score and clinicopathological data but they did not report the FSFI score itself 10 . Nevertheless, the overall published data report that vulvectomy has a negative impact on sexual function and quality of life 29 . Conversely, the skinning vulvectomy with split-thickness skin graft did not show negative impact in present study, but more studies are necessary to confirm this low side effect rate.
Comparison between surgery and medical treatment
The alternative to surgical resection of VIN or vulvar Paget disease lesions is destruction by CO2 laser vaporization 11 , cryocoagulation 32 or imiquimod 7 8 11 . Therapeutic vaccines for HPV 16 are currently undergoing clinical trials and may not as yet be recommended 33 . The risk of relapse seems unrelated to treatment type for some authors 8 or not significantly different between surgical resection (26% of relapse) and imiquimod (14%), which are themselves significantly superior to destruction by laser (45% of relapse), for others 27 . In a randomized trial of imiquimod vs. placebo, VIN lesions persisting after 1 year of treatment were observed in 15 out of 24 patients (62%) 12 . Imiquimod is also recommended as treatment inserm-00871204, version 1 -9 Oct 2013 for vulvar Paget disease [34] [35] [36] . Imiquimod seems to offer advantages over surgical resection because of a risk of relapse that is potentially lower than surgery 27 , probably due to the eradication of HPV 16, the causal agent of usual-type VIN 37 . However, treatment by imiquimod has one major disadvantage in that it does not allow a full histological analysis of lesions (and hence invasive cancer may be overlooked), and has non-negligible side effects such as pain, itching and skin erosion 12 . These side effects are all the more severe since the lesions are extensive and require application over several weeks 12 13 . In our series, skinning vulvectomy with split-thickness skin graft can alleviate pain in a few days with a VAS of 0 on the 10th day post-surgery, while maintaining good functionality in terms of sexuality and quality of life in the long term once healing has occurred.
Surgical technical aspect
Of note, one of the limits of skinning vulvectomy with split-thickness skin graft is linked to the seat of the lesions as shown in our study. Posterior and lateral lesions are the site of predilection, whereas skin grafts are less likely to take on anterior lesions and in particular lesions of the clitoris. inserm-00871204, version 1 -9 Oct 2013
Conclusion:
The ideal treatment for VIN or vulvar Paget disease should be acceptable to patients, alleviate symptoms, enable diagnosis of possible invasion, eliminate the risk of relapse by performing full resection of lesions and removing the causal agent, and preserve quality of life (body image and sexuality in particular). Skinning vulvectomy with split-thickness skin graft fulfills a certain number of these objectives (acceptability and postoperative comfort, full analysis of lesions, possibility of wide excision margins), in particular in posterolateral lesions. However, given the high relapse rate observed, adjuvant treatments warrant investigation, in particular etiological treatments such as therapeutic vaccination 33 or immune response modulators that facilitate HPV clearance 37 in extended and multifocal forms.
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